Semaglutide ER Visits: Shocking CDC Findings Revealed
In a surprising twist, recent CDC findings reveal an alarming rise in semaglutide ER visits, spotlighting concerns over side effects like GI hypoglycemia. As this popular treatment for type 2 diabetes and obesity continues to gain traction, understanding its impact on emergency room trends is essential for both healthcare providers and patients.








